The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 23, 2021

Filed:

Dec. 06, 2017
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Jun Woo Kim, Mountain View, CA (US);

Jennifer R. Cochran, Stanford, CA (US);

Eric Alejandro Sweet, San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 47/64 (2017.01); C07K 14/475 (2006.01); C12N 15/74 (2006.01); C12N 15/85 (2006.01); C07K 14/52 (2006.01);
U.S. Cl.
CPC ...
A61K 38/185 (2013.01); A61K 47/6425 (2017.08); C07K 14/475 (2013.01); C07K 14/52 (2013.01); C12N 15/74 (2013.01); C12N 15/85 (2013.01); C07K 2317/92 (2013.01); C07K 2319/033 (2013.01); C12N 2015/8518 (2013.01);
Abstract

Provided are ciliary neurotrophic factor receptor (CNTFR) ligands. In certain aspects, a CNTFR ligand of the present disclosure exhibits increased affinity for CNTFR relative to the corresponding wild-type CNTFR ligand. In certain aspects, a CNTFR ligand of the present disclosure results in reduced binding affinity of glycoprotein 130 (gp130), leukemia inhibitory factor receptor (LIFR), or both, for a complex including the CNTFR ligand and CNTFR, relative to the binding affinity for a complex including the corresponding wild-type CNTFR ligand and CNTFR. In certain aspects, a CNTFR ligand of the present disclosure has both of the aforementioned properties. Also provided are pharmaceutical compositions including the CNTFR ligands, as well as methods of using the CNTFR ligands.


Find Patent Forward Citations

Loading…